Wikidata

(Q61980834)

English

Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS

clinical trial

In more languages

Statements

short name
MITOTARGET (English)
0 references
title
Phase II/III, Multicenter, Randomized, Parallel Group, Double-blind, Placebo Controlled Study to Assess Safety and Efficacy of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Belgium
0 references
France
0 references
Germany
0 references
Spain
0 references
United Kingdom
0 references
start time
30 April 2009
0 references
end time
30 September 2011
0 references
number of participants
512
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980834&oldid=2095748384"